| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.66B | 11.46B | 10.54B | 10.13B | 8.56B |
| Gross Profit | 5.95B | 5.46B | 5.05B | 4.84B | 4.21B |
| EBITDA | 1.90B | 1.65B | 1.58B | 1.15B | 1.30B |
| Net Income | 436.00M | 490.00M | 538.80M | 142.50M | 369.70M |
Balance Sheet | |||||
| Total Assets | 9.79B | 9.95B | 8.05B | 8.02B | 7.07B |
| Cash, Cash Equivalents and Short-Term Investments | 854.00M | 731.00M | 1.15B | 1.58B | 1.31B |
| Total Debt | 3.68B | 3.74B | 2.61B | 2.45B | 2.37B |
| Total Liabilities | 6.35B | 6.58B | 5.18B | 5.39B | 4.73B |
| Stockholders Equity | 2.99B | 2.92B | 2.46B | 2.12B | 1.93B |
Cash Flow | |||||
| Free Cash Flow | 1.00B | 713.00M | 611.30M | 735.00M | 1.02B |
| Operating Cash Flow | 1.37B | 1.23B | 1.14B | 1.08B | 1.27B |
| Investing Cash Flow | -402.00M | -1.49B | -543.50M | -320.90M | -848.10M |
| Financing Cash Flow | -813.00M | -141.00M | -1.01B | -479.20M | -83.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.98B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
68 Neutral | £3.63B | 9.49 | 15.14% | 1.21% | 10.51% | -7.47% | |
65 Neutral | £1.53B | 6.72 | 105.88% | 3.99% | 4.39% | -1.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | £260.24M | -0.65 | -155.17% | ― | -15.00% | 21.71% | |
52 Neutral | £560.53M | -8.29 | 12.75% | ― | -1.91% | ― | |
41 Neutral | £260.28M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |